Human herpesvirus 8-encoded cytokines

Future Virology

Volumn 5, Issue 2, 2010, Pages 197-206

  Nicholas, John ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Angiogenesis; HHV 8; Human herpesvirus 8; Kaposi's sarcoma; Multicentric Castleman's disease; Pathogenesis; Primary effusion lymphoma; Signal transduction; VCCL; VIL 6; Viral IL 6

Indexed keywords

CCL1 CHEMOKINE; CYTOKINE; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1;

AMINO ACID SEQUENCE; ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; ANGIOGENESIS; B CELL LYMPHOMA; CYTOKINE PRODUCTION; HUMAN; HUMAN HERPESVIRUS 8; IMMUNE RESPONSE; IMMUNOREGULATION; KAPOSI SARCOMA; MOLECULAR RECOGNITION; NONHUMAN; PRIMARY EFFUSION LYMPHOMA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; RECEPTOR BINDING; REVIEW; SIGNAL TRANSDUCTION; VIRAL GENETICS; VIRUS CELL INTERACTION; VIRUS PATHOGENESIS;

EID: 77649299948     PISSN: 17460794     EISSN: None     Source Type: Journal    
DOI: 10.2217/fvl.10.2     Document Type: Review

References (77)

1. Chang Y, Cesarman E, Pessin MS et al.: Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266, 1865-1869 (1994)
2. Soulier J, Grollet L, Oksenhendler E et al.: Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood 86, 1276-1280 (1995).
3. Burger R, Wendler J, Antoni K, Helm G, Kalden JR, Gramatzki M: Interleukin-6 production in B-cell neoplasias and Castleman's disease: evidence for an additional paracrine loop. Ann. Hematol. 69, 25-31 (1994).
4. Hsu SM, Waldron JA, Xie SS, Barlogie B: Expression of interleukin-6 in Castleman's disease. Hum. Pathol. 24, 833-839 (1993).
5. Ishiyama T, Nakamura S, Akimoto Y et al.: Immunodeficiency and IL-6 production by peripheral blood monocytes in multicentric Castleman's disease. Br. J. Haematol. 86, 483-489 (1994).
6. Miles SA, Rezai AR, Salazar-Gonzalez JF et al.: AIDS Kaposi sarcoma-derived cells produce and respond to interleukin 6. Proc. Natl Acad. Sci. USA 87, 4068-4072 (1990).
7. Yoshizaki K, Matsuda T, Nishimoto N et al.: Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman's disease. Blood 74, 1360-1367 (1989).
8. Arvanitakis L, Mesri EA, Nador RG et al.: Establishment and characterization of a primary effusion (body cavity-based) lymphoma cell line (BC-3) harboring Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in the absence of Epstein-Barr virus. Blood 88, 2648-2654 (1996).
9. Carbone A, Gloghini A, Vaccher E et al.: Kaposi's sarcoma-associated herpesvirus DNA sequences in AIDS-related and AIDS-unrelated lymphomatous effusions. Br. J. Haematol. 94, 533-543 (1996).
10. Gaidano G, Cechova K, Chang Y, Moore PS, Knowles DM, Dalla-Favera R: Establishment of AIDS-related lymphoma cell lines from lymphomatous effusions. Leukemia 10, 1237-1240 (1996).
11. Nicholas J, Ruvolo VR, Burns WH et al.: Kaposi's sarcoma-associated human herpesvirus-8 encodes homologues of macrophage inflammatory protein-1 and interleukin-6. Nat. Med. 3, 287-292 (1997).
12. Moore PS, Boshoff C, Weiss RA, Chang Y: Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV. Science 274, 1739-1744 (1996)
13. Neipel F, Albrecht JC, Ensser A et al.: Human herpesvirus 8 encodes a homolog of interleukin-6. J. Virol. 71, 839-842 (1997).
14. Neipel F, Albrecht JC, Fleckenstein B: Cell-homologous genes in the Kaposi's sarcoma-associated rhadinovirus human herpesvirus 8: determinants of its pathogenicity? J. Virol. 71, 4187-4192 (1997).
15. Nicholas J, Ruvolo V, Zong J et al.: A single 13-kilobase divergent locus in the Kaposi sarcoma-associated herpesvirus (human herpesvirus 8) genome contains nine open reading frames that are homologous to or related to cellular proteins. J. Virol. 71, 1963-1974 (1997).
16. Russo JJ, Bohenzky RA, Chien MC et al.: Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). Proc. Natl Acad. Sci. USA 93, 14862-14867 (1996).
17. Boshoff C, Endo Y, Collins PD et al.: Angiogenic and HIV-inhibitory functions of KSHV-encoded chemokines. Science 278, 290-294 (1997).
18. Stine JT, Wood C, Hill M et al.: KSHV-encoded CC chemokine vMIP-III is a CCR4 agonist, stimulates angiogenesis, and selectively chemoattracts TH2 cells. Blood 95, 1151-1157 (2000).
19. Krishnan HH, Naranatt PP, Smith MS, Zeng L, Bloomer C, Chandran B: Concurrent expression of latent and a limited number of lytic genes with immune modulation and anti-apoptotic function by Kaposi's sarcoma-associated herpesvirus early during infection of primary endothelial and fibroblast cells and subsequent decline of lytic gene expression. J. Virol. 78, 3601-3620 (2004).
20. Jenner RG, Alba MM, Boshoff C, Kellam P: Kaposi's sarcoma-associated herpesvirus latent and lytic gene expression as revealed by DNA arrays. J. Virol. 75, 891-902 (2001).
21. Paulose-Murphy M, Ha NK, Xiang C et al.: Transcription program of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus). J. Virol. 75, 4843-4853 (2001).
22. Choi YB, Nicholas J: Autocrine and paracrine promotion of cell survival and virus replication by human herpesvirus 8 chemokines. J. Virol. 82, 6501-6513 (2008).
23. Chen D, Sandford G, Nicholas J: Intracellular signaling mechanisms and activities of human herpesvirus 8 interleukin-6. J. Virol. 83, 722-733 (2009).
24. Chow D, He X, Snow AL, Rose-John S, Garcia KC: Structure of an extracellular gp130 cytokine receptor signaling complex. Science 291, 2150-2155 (2001)
25. Boulanger MJ, Chow DC, Brevnova EE, Garcia KC: Hexameric structure and assembly of the interleukin-6/IL-6
26. Hideshima T, Chauhan D, Teoh G et al.: Characterization of signaling cascades triggered by human interleukin-6 versus Kaposi's sarcoma-associated herpes virus-encoded viral interleukin 6. Clin. Cancer Res. 6, 1180-1189 (2000).
27. Wan X, Wang H, Nicholas J: Human herpesvirus 8 interleukin-6 (vIL-6) signals through gp130 but has structural and receptor-binding properties distinct from those of human IL-6. J. Virol. 73, 8268-8278 (1999).
28. Molden J, Chang Y, You Y, Moore PS, Goldsmith MA: A Kaposi's sarcoma-associated herpesvirus-encoded cytokine homolog (vIL-6) activates signaling through the shared gp130 receptor subunit. J. Biol. Chem. 272, 19625-19631 (1997).
29. Osborne J, Moore PS, Chang Y: KSHV-encoded viral IL-6 activates multiple human IL-6 signaling pathways. Hum. Immunol. 60, 921-927 (1999).
30. Boulanger MJ, Chow DC, Brevnova E et al.: Molecular mechanisms for viral mimicry of a human cytokine: activation of gp130 by HHV-8 interleukin-6. J. Mol. Biol. 335, 641-654 (2004).
31. Hu F, Nicholas J: Signal transduction by human herpesvirus 8 viral interleukin-6 (vIL-6) is modulated by the nonsignaling gp80 subunit of the IL-6 receptor complex and is distinct from signaling induced by human IL-6. J. Virol. 80, 10874-10878 (2006).
32. Li H, Nicholas J: Identification of amino acid residues of gp130 signal transducer and gp80 a receptor subunit that are involved in ligand binding and signaling by human herpesvirus 8-encoded interleukin-6. J. Virol. 76, 5627-5636 (2002).
33. Chen D, Nicholas J: Structural requirements for gp80 independence of human herpesvirus 8 interleukin-6 (vIL-6) and evidence for gp80 stabilization of gp130 signaling complexes induced by vIL-6. J. Virol. 80, 9811-9821 (2006).
34. Adam N, Rabe B, Suthaus J, Grotzinger J, Rose-John S, Scheller J: Unraveling viral interleukin-6 binding to gp130 and activation of STAT-signaling pathways independently of the interleukin-6 receptor. J. Virol. 83, 5117-5126 (2009).
35. Dela Cruz CS, Viswanathan SR, El-Guindy AS, Shedd D, Miller G: Complex N-linked glycans on Asn-89 of Kaposi sarcoma herpes virus-encoded interleukin-6 mediate optimal function by affecting cytokine protein conformation. J. Biol. Chem. 284, 29269-29282 (2009).
36. Chen D, Choi YB, Sandford G, Nicholas J: Determinants of secretion and intracellular localization of human herpesvirus 8 interleukin-6. J. Virol. 83(13) 6874-6882 (2009).
37. Parekh RB, Dwek RA, Rademacher TW, Opdenakker G, Van Damme J: Glycosylation of interleukin-6 purified from normal human blood mononuclear cells. Eur. J. Biochem. 203, 135-141 (1992).
38. Santhanam U, Ghrayeb J, Sehgal PB, May LT: Post-translational modifications of human interleukin-6. Arch. Biochem. Biophys. 274, 161-170 (1989).
39. Burger R, Neipel F, Fleckenstein B et al.: Human herpesvirus type 8 interleukin-6 homologue is functionally active on human myeloma cells. Blood 91, 1858-1863 (1998).
40. Hirano T, Nakajima K, Hibi M: Signaling mechanisms through gp130: a model of the cytokine system. Cytokine Growth Factor Rev. 8, 241-252 (1997).
41. Jones KD, Aoki Y, Chang Y, Moore PS, Yarchoan R, Tosato G: Involvement of interleukin-10 (IL-10) and viral IL-6 in the spontaneous growth of Kaposi's sarcoma herpesvirus-associated infected primary effusion lymphoma cells. Blood 94, 2871-2879 (1999).
42. Mori Y, Nishimoto N, Ohno M et al.: Human herpesvirus 8-encoded interleukin-6 homologue (viral IL-6) induces endogenous human IL-6 secretion. J. Med. Virol. 61, 332-335 (2000).
43. Meads MB, Medveczky PG: Kaposi's sarcoma-associated herpesvirus-encoded viral interleukin-6 is secreted and modified differently than human interleukin-6: evidence for a unique autocrine signaling mechanism. J. Biol. Chem. 279, 51793-51803 (2004).
44. Chatterjee M, Osborne J, Bestetti G, Chang Y, Moore PS: Viral IL-6-induced cell proliferation and immune evasion of interferon activity. Science 298, 1432-1435 (2002).
45. Asou H, Said JW, Yang R et al.: Mechanisms of growth control of Kaposi's sarcoma-associated herpes virus-associated primary effusion lymphoma cells. Blood 91, 2475-2481 (1998).
46. Chen L, Lagunoff M: The KSHV viral interleukin-6 is not essential for latency or lytic replication in BJAB cells. Virology 359, 425-435 (2007).
47. Dittmer DP, Gonzalez CM, Vahrson W, DeWire SM, Hines-Boykin R, Damania B: Whole-genome transcription profiling of rhesus monkey rhadinovirus. J. Virol. 79, 8637-8650 (2005).
48. O'Connor CM, Kedes DH: Rhesus monkey rhadinovirus: a model for the study of KSHV. Curr. Top. Microbiol. Immunol. 312, 43-69 (2007).
49. Orzechowska BU, Powers MF, Sprague J et al.: Rhesus macaque rhadinovirus-associated non-Hodgkin lymphoma: animal model for KSHV-associated malignancies. Blood 112, 4227-4234 (2008).
50. Lu M, Suen J, Frias C et al.: Dissection of the Kaposi's sarcoma-associated herpesvirus gene expression program by using the viral DNA replication inhibitor cidofovir. J. Virol. 78, 13637-13652 (2004).
51. Sun R, Lin SF, Staskus K et al.: Kinetics of Kaposi's sarcoma-associated herpesvirus gene expression. J. Virol. 73, 2232-2242 (1999).
52. Aoki Y, Jaffe ES, Chang Y et al.: Angiogenesis and hematopoiesis induced by Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6. Blood 93, 4034-4043 (1999).
53. Aoki Y, Tosato G: Role of vascular endothelial growth factor/vascular permeability factor in the pathogenesis of Kaposi's sarcoma-associated herpesvirus-infected primary effusion lymphomas. Blood 94, 4247-4254 (1999).
54. Zhang YJ, Bonaparte RS, Patel D, Stein DA, Iversen PL: Blockade of viral interleukin-6 expression of Kaposi's sarcoma-associated herpesvirus. Mol. Cancer Ther. 7, 712-720 (2008).
55. Aoki Y, Feldman GM, Tosato G: Inhibition of STAT3 signaling induces apoptosis and decreases survivin expression in primary effusion lymphoma. Blood 101, 1535-1542 (2003).
56. Benekli M, Baer MR, Baumann H, Wetzler M: Signal transducer and activator of transcription proteins in leukemias. Blood 101, 2940-2954 (2003).
57. Bowman T, Garcia R, Turkson J, Jove R: STATs in oncogenesis. Oncogene 19, 2474-2488 (2000).
58. Hodge DR, Hurt EM, Farrar WL: The role of IL-6 and STAT3 in inflammation and cancer. Eur. J. Cancer 41, 2502-2512 (2005).
59. Glaunsinger B, Ganem D: Highly selective escape from KSHV-mediated host mRNA shutoff and its implications for viral pathogenesis. J. Exp. Med. 200, 391-398 (2004).
60. Glaunsinger B, Ganem D: Lytic KSHV infection inhibits host gene expression by accelerating global mRNA turnover. Mol. Cell 13, 713-723 (2004).
61. Dairaghi DJ, Fan RA, McMaster BE, Hanley MR, Schall TJ: HHV8-encoded vMIP-I selectively engages chemokine receptor CCR8. Agonist and antagonist profiles of viral chemokines. J. Biol. Chem. 274, 21569-21574 (1999).
62. Endres MJ, Garlisi CG, Xiao H, Shan L, Hedrick JA: The Kaposi's sarcoma-related herpesvirus (KSHV)-encoded chemokine vMIP-I is a specific agonist for the CC chemokine receptor (CCR)8. J. Exp. Med. 189, 1993-1998 (1999).
63. Sozzani S, Luini W, Bianchi G et al.: The viral chemokine macrophage inflammatory protein-II is a selective Th2 chemoattractant. Blood 92, 4036-4039 (1998).
64. Geras-Raaka E, Varma A, Clark-Lewis I, Gershengorn MC: Kaposi's sarcoma-associated herpesvirus (KSHV) chemokine vMIP-II and human SDF-1α inhibit signaling by KSHV G protein-coupled receptor. Biochem. Biophys. Res. Commun. 253, 725-727 (1998).
65. Luttichau HR: The herpesvirus 8 encoded chemokines vCCL2 (vMIP-II) and vCCL3 (vMIP-III) target the human but not the murine lymphotactin receptor. Virol. J. 5, 50 (2008).
66. Luttichau HR, Johnsen AH, Jurlander J, Rosenkilde MM, Schwartz TW: Kaposi sarcoma-associated herpes virus targets the lymphotactin receptor with both a broad spectrum antagonist vCCL2 and a highly selective and potent agonist vCCL3. J. Biol. Chem. 282, 17794-17805 (2007).
67. Nakano K, Isegawa Y, Zou P, Tadagaki K, Inagi R, Yamanishi K: Kaposi's sarcoma-associated herpesvirus (KSHV)-encoded vMIP-I and vMIP-II induce signal transduction and chemotaxis in monocytic cells. Arch. Virol. 148, 871-890 (2003).
68. Shan L, Qiao X, Oldham E et al.: Identification of viral macrophage inflammatory protein (vMIP)-II as a ligand for GPR5/XCR1. Biochem. Biophys. Res. Commun. 268, 938-941 (2000).
69. Kledal TN, Rosenkilde MM, Coulin F et al.: A broad-spectrum chemokine antagonist encoded by Kaposi's sarcoma-associated herpesvirus. Science 277, 1656-1659 (1997).
70. Rubant S, Ludwig RJ, Pfeffer J et al.: Eukaryotic expression of the broad-spectrum chemokine receptor antagonist vMIP-II and its effects on T-cell function in vitro and in vivo. Exp. Dermatol. 15, 634-642 (2006).
71. Chen S, Bacon KB, Li L et al.: In vivo inhibition of CC and CX3C chemokine-induced leukocyte infiltration and attenuation of glomerulonephritis in Wistar-Kyoto (WKY) rats by vMIP-II. J. Exp. Med. 188, 193-198 (1998).
72. Luttichau HR, Lewis IC, Gerstoft J, Schwartz TW: The herpesvirus 8-encoded chemokine vMIP-II, but not the poxvirus-encoded chemokine MC148, inhibits the CCR10 receptor. Eur. J. Immunol. 31, 1217-1220 (2001).
73. Weber KS, Grone HJ, Rocken M et al.: Selective recruitment of Th2-type cells and evasion from a cytotoxic immune response mediated by viral macrophage inhibitory protein-II. Eur. J. Immunol. 31, 2458-2466 (2001).
74. Liu C, Okruzhnov Y, Li H, Nicholas J: Human herpesvirus 8 (HHV-8)-encoded cytokines induce expression of and autocrine signaling by vascular endothelial growth factor (VEGF) in HHV-8-infected primary-effusion lymphoma cell lines and mediate VEGF-independent anti-apoptotic effects. J. Virol. 75, 10933-10940 (2001).
75. Feng P, Scott C, Lee SH, Cho NH, Jung JU: Manipulation of apoptosis by herpes viruses (Kaposi's sarcoma pathogenesis). Prog. Mol. Subcell. Biol. 36, 191-205 (2004).
76. Tschopp J, Thome M, Hofmann K, Meinl E: The fight of viruses against apoptosis. Curr. Opin. Genet. Dev. 8, 82-87 (1998).
77. Haque NS, Fallon JT, Pan JJ, Taubman MB, Harpel PC: Chemokine receptor-8 (CCR8) mediates human vascular smooth muscle cell chemotaxis and metalloproteinase-2 secretion. Blood 103, 1296-1304 (2004).